WO2019088590A3 - 마이코박테리움 파라고르도네의 항암 면역치료법 용도 - Google Patents

마이코박테리움 파라고르도네의 항암 면역치료법 용도 Download PDF

Info

Publication number
WO2019088590A3
WO2019088590A3 PCT/KR2018/012812 KR2018012812W WO2019088590A3 WO 2019088590 A3 WO2019088590 A3 WO 2019088590A3 KR 2018012812 W KR2018012812 W KR 2018012812W WO 2019088590 A3 WO2019088590 A3 WO 2019088590A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
cells
paragordonae
mycobacterium
cancer immunotherapy
Prior art date
Application number
PCT/KR2018/012812
Other languages
English (en)
French (fr)
Other versions
WO2019088590A2 (ko
Inventor
김범준
이소영
Original Assignee
서울대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교 산학협력단 filed Critical 서울대학교 산학협력단
Priority to US16/761,933 priority Critical patent/US11331350B2/en
Priority to JP2020524752A priority patent/JP7017011B2/ja
Publication of WO2019088590A2 publication Critical patent/WO2019088590A2/ko
Publication of WO2019088590A3 publication Critical patent/WO2019088590A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

마이코박테리움 파라고르도네(M. paragordonae)에 의한 항암 조절반응과 면역요법에 관한 것으로, 일 양상에 따른 마이코박테리움 파라고르도네는 암 세포에 대한 세포독성뿐만 아니라, 자연살해세포 또는 T 세포 매개 암 세포 독성을 갖고, 대식세포 또는 수지상 세포의 암 세포 독성조절 T 세포의 활성화를 억제함으로써 면역 반응을 유도하여 종양 형성을 억제하여 면역 항암제에 유용하게 사용될 수 있는 효과가 있다.
PCT/KR2018/012812 2017-11-06 2018-10-26 마이코박테리움 파라고르도네의 항암 면역치료법 용도 WO2019088590A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16/761,933 US11331350B2 (en) 2017-11-06 2018-10-26 Use of Mycobacterium paragordonae for cancer immunotherapy
JP2020524752A JP7017011B2 (ja) 2017-11-06 2018-10-26 マイコバクテリウムパラゴルドネの抗癌免疫治療法用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170146770 2017-11-06
KR10-2017-0146770 2017-11-06

Publications (2)

Publication Number Publication Date
WO2019088590A2 WO2019088590A2 (ko) 2019-05-09
WO2019088590A3 true WO2019088590A3 (ko) 2019-07-04

Family

ID=66331460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/012812 WO2019088590A2 (ko) 2017-11-06 2018-10-26 마이코박테리움 파라고르도네의 항암 면역치료법 용도

Country Status (4)

Country Link
US (1) US11331350B2 (ko)
JP (1) JP7017011B2 (ko)
KR (1) KR102115468B1 (ko)
WO (1) WO2019088590A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101515934B1 (ko) * 2014-11-13 2015-05-04 유라이닝(주) 관로보수용 보수튜브 연화 및 보관장치 및 이를 이용한 비개착식 관로보수 방법
TW202138005A (zh) * 2019-12-27 2021-10-16 特定非營利活動法人北東日本研究機構 癌症治療方法及醫藥

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010033132A (ko) * 1997-12-23 2001-04-25 왓슨 제임스 디. 미코박테리움 바카이에서 유도한 조성물 및 이의 이용방법
KR20160021933A (ko) * 2014-08-18 2016-02-29 서울대학교산학협력단 신규한 온도 민감성 마이코박테리아 균주 및 이를 포함하는 마이코박테리아 감염증에 대한 백신 조성물
KR20160093023A (ko) * 2013-12-20 2016-08-05 이모듈런 테라퓨틱스 리미티드 암 치료에 사용하기 위한 체크포인트 저해제와 마이코박테리움 전체 세포

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083443A1 (es) 2010-10-13 2013-02-27 Bioniche Life Sciences Inc Una composicion que comprende arn bacteriano y paredes celulares bacterianas, metodo para elaborar dicha composicion y sus usos

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010033132A (ko) * 1997-12-23 2001-04-25 왓슨 제임스 디. 미코박테리움 바카이에서 유도한 조성물 및 이의 이용방법
KR20160093023A (ko) * 2013-12-20 2016-08-05 이모듈런 테라퓨틱스 리미티드 암 치료에 사용하기 위한 체크포인트 저해제와 마이코박테리움 전체 세포
KR20160021933A (ko) * 2014-08-18 2016-02-29 서울대학교산학협력단 신규한 온도 민감성 마이코박테리아 균주 및 이를 포함하는 마이코박테리아 감염증에 대한 백신 조성물

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FOWLER, D. W.: "Mycobacteria activate gamma delta T- cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy", CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 61, no. 445, 15 October 2011 (2011-10-15), pages 535 - 547, XP035033381 *
TORTOLI, E .: "Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium", CLINICAL MICROBIOLOGY REVIEWS, vol. 27, no. 4, 2014, pages 727 - 752, XP55623656 *

Also Published As

Publication number Publication date
WO2019088590A2 (ko) 2019-05-09
JP7017011B2 (ja) 2022-02-08
KR20190051811A (ko) 2019-05-15
US20200323928A1 (en) 2020-10-15
US11331350B2 (en) 2022-05-17
JP2021501777A (ja) 2021-01-21
KR102115468B1 (ko) 2020-05-26

Similar Documents

Publication Publication Date Title
WO2016109546A3 (en) Methods and compositions for prognosis and treatment of cancers
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
WO2016105542A3 (en) Nanoparticle compositions and methods for immunotherapy
WO2015195531A3 (en) Syntac polypeptides and uses thereof
MX2019011496A (es) Composiciones de niraparib.
MX2019006539A (es) Sistemas y metodos para la extraccion de productos naturales.
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
EP4234483A3 (en) Synthesis and hydrogen storage properties of novel metal hydrides
WO2015120062A8 (en) Therapeutic compounds and compositions
EP4299133A3 (en) Compositions and methods for the delivery of therapeutics
WO2017122098A3 (en) Anti pd-l antibodies for enhancing the potency of superantigen mediated cancer immunotherapy
WO2018022238A8 (en) Catalyst compositions and use thereof
WO2017214170A3 (en) Baff-r antibodies and uses thereof
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
WO2016100732A3 (en) Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
MX2019005349A (es) Uso de analogos de sangliferina macrociclicos como compuestos anticancerigenos.
WO2019088590A3 (ko) 마이코박테리움 파라고르도네의 항암 면역치료법 용도
WO2015089402A8 (en) Methods and compositions related to hsp90 inhibitors and breast cancer
PH12020551535A1 (en) Vaccine compositions
WO2016130581A8 (en) Combination cancer therapy
WO2016141042A3 (en) Novel compositions, uses and methods for making them
WO2015104720A3 (en) Parenteral compositions of bendamustine
WO2017087917A3 (en) Bicarbonate biosensors, calcium biosensors, and uses thereof
WO2016109002A3 (en) Methods and compositions for the treatment of radiation-related disorders
WO2016160874A3 (en) Polyether polyol compositions

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2020524752

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18874155

Country of ref document: EP

Kind code of ref document: A2